Vivos (RDGL) EPS (Diluted) (QoQ) (2012 - 2025)
Vivos (RDGL) EPS (Diluted) (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Vivos | 27.30 Mn | 25.74 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -113.34% |
| Sep 30, 2025 | 21.55% |
| Jun 30, 2025 | 23.56% |
| Mar 31, 2025 | 25.44% |
| Dec 31, 2024 | -26.69% |
| Sep 30, 2024 | -57.95% |
| Jun 30, 2024 | 12.98% |
| Mar 31, 2024 | 50.85% |
| Dec 31, 2023 | -61.94% |
| Sep 30, 2023 | 26.49% |
| Jun 30, 2023 | -257.90% |
| Mar 31, 2023 | 65.89% |
| Dec 31, 2022 | -149.24% |
| Sep 30, 2022 | 64.82% |
| Jun 30, 2022 | -4,438.07% |
| Mar 31, 2022 | -292.70% |
| Dec 31, 2021 | 11.40% |
| Sep 30, 2021 | 89.19% |
| Jun 30, 2021 | -545.47% |
| Mar 31, 2021 | 4.60% |